TCL Archive In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy September 10, 1982
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive House Reprogramming Of NCI Funds Analyzed; Community Programs Would Be Hurt July 13, 1979
